The Food and Drug Administration has told food manufacturers the psychoactive mushroom Amanita muscaria isn't authorized for food, including edibles, because it doesn't meet safety standards.
The patient was in kidney failure and her immune system would reject a human organ. Scientists hope genetically modified pig organs prove safe and will alleviate the organ shortage and save lives.
The gene-editing technique is effective for treating some illnesses but it's been too expensive to consider it for rare conditions. A new approach in the works could make it more widely available.
The federal government has allocated $1.15 billion so far on long COVID research, without bringing any new treatments to market. Patients and scientists say it's time to push harder for breakthroughs.
About two dozen chimpanzees deemed too feeble to be moved a few years ago will be going to Chimp Haven after all. The NIH said originally they'd be kept in New Mexico for their own safety.
As more states ban gender care for youth, doctors and clinics in Minnesota are building up capacity to help the influx of trans patients who are traveling or moving to the state for care.
Some clinics will now check your breast scan for arterial calcification, which can be a sign of heart disease risk. But questions remain about the approach.
For 22 years, Jason Mazzola’s life was defined by a genetic condition that can cause autism and intellectual disability. Then he started taking an experimental drug.
A virtual version of a fruit fly’s visual system could help scientists understand how brain networks process information. The model could also lead to more efficient AI systems.
A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are also getting diagnosed, and at younger ages.
